Search research articles
Contact Us
Filters
Showing results (221-230 of 251) with videos related to
Page
of 26
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
October 27, 2018
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy
Alison K Yoder, Jillian R Gunther, Sarah A Milgrom, et al.
Leukemia & Lymphoma
|
January 24, 2020
Pretreatment SUV<sub>max</sub> may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL
Paolo Strati, Mohamed Amin Ahmed, Loretta J Nastoupil, et al.
Blood Advances
|
January 10, 2022
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement
Serkan Akin, Chitra Hosing, Issa Khouri, et al.
JAMA Network Open
|
April 7, 2025
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy
James P Long, Rishab Prakash, Paul Edelkamp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 27, 2022
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B
Man-Fung Yuen, Chi-Yi Chen, Chun-Jen Liu, et al.
Blood Advances
|
May 1, 2019
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma
Chelsea C Pinnix, Sarah A Milgrom, Chan Yoon Cheah, et al.
Blood Advances
|
August 19, 2025
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell Lymphoma
Swaminathan P Iyer, Neha Mehta-Shah, Ranjana H Advani, et al.
Leukemia & Lymphoma
|
January 22, 2021
The impact of cell-of-origin, MYC/Bcl-2 dual expression and <i>MYC</i> rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy
Alexander Augustyn, L Jeffrey Medeiros, Ethan B Ludmir, et al.
Leukemia
|
September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy
Paolo Strati, Andrew P Jallouk, Ryan Sun, et al.
Oncotarget
|
January 26, 2023
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)
Leo I Gordon, Reem Karmali, Jason B Kaplan, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 251) with videos related to
Sort By:
Page
of 26
Clinical Lymphoma, Myeloma & Leukemia
|
October 27, 2018
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy
Alison K Yoder, Jillian R Gunther, Sarah A Milgrom, et al.
Leukemia & Lymphoma
|
January 24, 2020
Pretreatment SUV<sub>max</sub> may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL
Paolo Strati, Mohamed Amin Ahmed, Loretta J Nastoupil, et al.
Blood Advances
|
January 10, 2022
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement
Serkan Akin, Chitra Hosing, Issa Khouri, et al.
JAMA Network Open
|
April 7, 2025
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy
James P Long, Rishab Prakash, Paul Edelkamp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 27, 2022
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B
Man-Fung Yuen, Chi-Yi Chen, Chun-Jen Liu, et al.
Blood Advances
|
May 1, 2019
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma
Chelsea C Pinnix, Sarah A Milgrom, Chan Yoon Cheah, et al.
Blood Advances
|
August 19, 2025
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell Lymphoma
Swaminathan P Iyer, Neha Mehta-Shah, Ranjana H Advani, et al.
Leukemia & Lymphoma
|
January 22, 2021
The impact of cell-of-origin, MYC/Bcl-2 dual expression and <i>MYC</i> rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy
Alexander Augustyn, L Jeffrey Medeiros, Ethan B Ludmir, et al.
Leukemia
|
September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy
Paolo Strati, Andrew P Jallouk, Ryan Sun, et al.
Oncotarget
|
January 26, 2023
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)
Leo I Gordon, Reem Karmali, Jason B Kaplan, et al.
Page
of 26